$1.27 Billion is the total value of BRIDGER MANAGEMENT, LLC's 31 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 42.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDCO | Sell | MEDICINES CO | $84,392,000 | +6.3% | 2,314,014 | -18.6% | 6.62% | +5.4% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $65,694,000 | -6.1% | 4,171,065 | -12.6% | 5.16% | -6.8% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $58,336,000 | -1.9% | 147,619 | -13.9% | 4.58% | -2.7% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $38,554,000 | -7.4% | 1,083,598 | -12.5% | 3.03% | -8.1% |
| MGM | Sell | MGM RESORTS INTERNATIONAL | $38,228,000 | -15.8% | 1,338,061 | -24.4% | 3.00% | -16.5% |
| VRSN | Sell | VERISIGN INC | $36,102,000 | -2.0% | 172,604 | -15.0% | 2.83% | -2.8% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $34,582,000 | -50.4% | 1,719,642 | -1.9% | 2.71% | -50.8% |
| LBRDA | Sell | LIBERTY BROADBAND CORP | $31,421,000 | -12.1% | 305,535 | -21.7% | 2.47% | -12.9% |
| TGTX | Sell | TG THERAPEUTICS INC | $29,537,000 | -8.2% | 3,414,668 | -14.7% | 2.32% | -9.0% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $18,710,000 | -30.2% | 1,247,366 | -18.4% | 1.47% | -30.8% |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $17,937,000 | -34.8% | 152,344 | -29.3% | 1.41% | -35.4% |
| ENPH | Exit | ENPHASE ENERGY INC | $0 | – | -724,723 | -100.0% | -0.53% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -183,141 | -100.0% | -0.91% | – |
| CZR | Exit | CAESARS ENTMT CORP | $0 | – | -1,377,004 | -100.0% | -0.95% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -514,105 | -100.0% | -1.39% | – |
| VSAT | Exit | VIASAT INC | $0 | – | -480,179 | -100.0% | -2.95% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -1,424,239 | -100.0% | -3.54% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -331,069 | -100.0% | -4.01% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -4,181,892 | -100.0% | -4.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.